CN1166680C - 新颖的雄激素 - Google Patents
新颖的雄激素 Download PDFInfo
- Publication number
- CN1166680C CN1166680C CNB008164959A CN00816495A CN1166680C CN 1166680 C CN1166680 C CN 1166680C CN B008164959 A CNB008164959 A CN B008164959A CN 00816495 A CN00816495 A CN 00816495A CN 1166680 C CN1166680 C CN 1166680C
- Authority
- CN
- China
- Prior art keywords
- methyl
- alkyl
- methyleneestr
- hydrogen
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL99204080.8 | 1999-12-02 | ||
| EP99204080 | 1999-12-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1402735A CN1402735A (zh) | 2003-03-12 |
| CN1166680C true CN1166680C (zh) | 2004-09-15 |
Family
ID=8240955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB008164959A Expired - Fee Related CN1166680C (zh) | 1999-12-02 | 2000-11-29 | 新颖的雄激素 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6706700B2 (enExample) |
| EP (1) | EP1237904B1 (enExample) |
| JP (1) | JP2003515543A (enExample) |
| CN (1) | CN1166680C (enExample) |
| AR (1) | AR026655A1 (enExample) |
| AT (1) | ATE317396T1 (enExample) |
| AU (1) | AU778017B2 (enExample) |
| CA (1) | CA2390226A1 (enExample) |
| CO (1) | CO5251441A1 (enExample) |
| CY (1) | CY1106086T1 (enExample) |
| CZ (1) | CZ301376B6 (enExample) |
| DE (1) | DE60025958T2 (enExample) |
| DK (1) | DK1237904T3 (enExample) |
| ES (1) | ES2258037T3 (enExample) |
| HK (1) | HK1047596B (enExample) |
| HU (1) | HUP0203611A3 (enExample) |
| IL (1) | IL149424A (enExample) |
| MX (1) | MXPA02004939A (enExample) |
| NO (1) | NO322422B1 (enExample) |
| NZ (1) | NZ518753A (enExample) |
| PE (1) | PE20011033A1 (enExample) |
| PL (1) | PL202999B1 (enExample) |
| RU (1) | RU2242479C2 (enExample) |
| SK (1) | SK287095B6 (enExample) |
| TW (1) | TWI275593B (enExample) |
| WO (1) | WO2001040255A2 (enExample) |
| ZA (1) | ZA200203536B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5209600A (en) * | 1999-04-06 | 2000-10-23 | Akzo Nobel N.V. | Orally active androgens |
| RS51490B (sr) * | 2002-01-21 | 2011-04-30 | N.V. Organon | POSTUPAK ZA IZRADU 7α-METILSTEROIDA |
| US20080293683A1 (en) * | 2007-05-24 | 2008-11-27 | University Of Kansas Medical Center | Hormone Replacement Therapy |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| PL2764008T3 (pl) * | 2011-10-07 | 2017-04-28 | Estetra S.P.R.L. | Sposób wytwarzania estetrolu |
| JP6863547B2 (ja) | 2015-06-18 | 2021-04-21 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| JP6866560B2 (ja) | 2015-06-18 | 2021-04-28 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| MA44206B1 (fr) | 2015-06-18 | 2021-04-30 | Estetra Sprl | Comprimé orodispersible comprenant estetrol |
| LT3310345T (lt) | 2015-06-18 | 2021-06-25 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| CN111621141B (zh) * | 2020-06-12 | 2022-04-08 | 广西大学 | 一种缓释型二氧化氯-水性聚氨酯抗菌膜及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3086027A (en) * | 1960-01-22 | 1963-04-16 | Lilly Co Eli | 19-nor-4, 9(10)-steroids and process |
| IE60780B1 (en) | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
| DE19537626A1 (de) * | 1995-10-10 | 1997-04-17 | Jenapharm Gmbh | Steroide mit einer 14, 15-Methylengruppe |
| DE19827522A1 (de) * | 1998-06-22 | 1999-12-23 | Jenapharm Gmbh | 14,15-Cyclopropanosteroide der 19-Nor-Androstanreihe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| WO2000053619A1 (en) * | 1999-03-08 | 2000-09-14 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
-
2000
- 2000-11-29 PL PL355689A patent/PL202999B1/pl not_active IP Right Cessation
- 2000-11-29 JP JP2001541010A patent/JP2003515543A/ja active Pending
- 2000-11-29 AU AU28383/01A patent/AU778017B2/en not_active Ceased
- 2000-11-29 HU HU0203611A patent/HUP0203611A3/hu unknown
- 2000-11-29 RU RU2002117440/04A patent/RU2242479C2/ru not_active IP Right Cessation
- 2000-11-29 HK HK02109169.4A patent/HK1047596B/en not_active IP Right Cessation
- 2000-11-29 NZ NZ518753A patent/NZ518753A/en unknown
- 2000-11-29 AT AT00993259T patent/ATE317396T1/de not_active IP Right Cessation
- 2000-11-29 CZ CZ20021894A patent/CZ301376B6/cs not_active IP Right Cessation
- 2000-11-29 MX MXPA02004939A patent/MXPA02004939A/es active IP Right Grant
- 2000-11-29 DE DE60025958T patent/DE60025958T2/de not_active Expired - Lifetime
- 2000-11-29 IL IL149424A patent/IL149424A/en not_active IP Right Cessation
- 2000-11-29 EP EP00993259A patent/EP1237904B1/en not_active Expired - Lifetime
- 2000-11-29 US US10/148,820 patent/US6706700B2/en not_active Expired - Fee Related
- 2000-11-29 ES ES00993259T patent/ES2258037T3/es not_active Expired - Lifetime
- 2000-11-29 DK DK00993259T patent/DK1237904T3/da active
- 2000-11-29 SK SK758-2002A patent/SK287095B6/sk not_active IP Right Cessation
- 2000-11-29 CA CA002390226A patent/CA2390226A1/en not_active Abandoned
- 2000-11-29 WO PCT/EP2000/012009 patent/WO2001040255A2/en not_active Ceased
- 2000-11-29 CN CNB008164959A patent/CN1166680C/zh not_active Expired - Fee Related
- 2000-11-30 AR ARP000106304A patent/AR026655A1/es active IP Right Grant
- 2000-12-01 CO CO00092012A patent/CO5251441A1/es not_active Application Discontinuation
- 2000-12-01 PE PE2000001285A patent/PE20011033A1/es not_active Application Discontinuation
- 2000-12-02 TW TW089125707A patent/TWI275593B/zh not_active IP Right Cessation
-
2002
- 2002-05-03 ZA ZA200203536A patent/ZA200203536B/en unknown
- 2002-05-30 NO NO20022564A patent/NO322422B1/no not_active IP Right Cessation
-
2006
- 2006-04-10 CY CY20061100500T patent/CY1106086T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1026324C (zh) | 11β-(4-异丙烯基苯基)-4,9-雌二烯,其制法及含此化合物的药剂 | |
| CN1054133C (zh) | 17-螺亚甲基甾族化合物 | |
| CN1166680C (zh) | 新颖的雄激素 | |
| CN1358193A (zh) | 用于治疗的具有c-17烷基侧链和芳香a-环的甾族化合物 | |
| CN1257181C (zh) | 雄激素甾类化合物以及制备和使用它们的方法 | |
| HK1040718A1 (en) | Antigestagenic steroids with a fluorinated 17a-alkyl chain | |
| CN1360589A (zh) | 口服活性雄激素 | |
| CN1185249C (zh) | 在11位带有烃取代基的非芳香族雌激素甾族化合物 | |
| CN101061132A (zh) | 用于制备17-羟基-6β,7β;15β,16β-双亚甲基-17α-孕甾4-烯-3-酮-21-羧酸γ-内酯的方法和用于该方法的关键中间体 | |
| CN1027270C (zh) | 14,17β-桥亚乙基-14β-雌三烯和雌四烯的制备方法和含有它们的药物制剂 | |
| EP1163259B1 (en) | 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens | |
| CN1226304C (zh) | 作为雄激素的亚甲基类固醇 | |
| CN1481388A (zh) | 具有雄激素-孕激素混合活性的14(15)-不饱和的15-和/或16-取代的雄激素类 | |
| HK1081203B (en) | 9-alpha-substituted estratrienes as selectively active estrogen | |
| HK1081203A1 (en) | 9-Alpha-substituted estratrienes as selectively active estrogen | |
| AU2002224923A1 (en) | Methylene steroids as novel androgens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20070105 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20070105 Address after: Holland Patentee after: Organon NV Address before: Holland Arnhem Patentee before: Akzo Nobel N. V. |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040915 Termination date: 20101129 |